Concepedia

Author

Nuccia Morici

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano NiguardaORCID

Also Known As

Carlos Henrique Miranda, MORICI, NUCCIA, Marco Metra, N Morici, N. Morici, NUCCIA MORICI, Nuccia Morici, on behalf of the AltShock group

280

Publications

5.8K

Citations

37

H-Index

73

Concepts

All Affiliations

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano NiguardaIstituti di Ricovero e Cura a Carattere ScientificoUniversity of MilanAlessandro Manzoni HospitalPoliclinico San Matteo Fondazione
NM

About

Nuccia Morici is an author at Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

23

38

1.7K

2

Emergency Medicine

16

19

762

3

Public Health

15

16

395

4

Diabetes

2

2

90

5

Biochemistry

1

1

66

Nuccia Morici

×

80

Publications

4.2K

Citations

31

H-Index

YearCitations

Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL)

Carlo Briguori, Flavio Airoldi, Davide D’Andrea,

Circulation

2007

455

Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine Treatment

Flavio Airoldi, Antonio Colombo, Nuccia Morici,

Circulation

2007

452

Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis

Alaide Chieffo, Nuccia Morici, Francesco Maisano,

Circulation

2006

310

Management and Long-Term Prognosis of Spontaneous Coronary Artery Dissection

Corrado Lettieri, Dennis Zavalloni, Roberta Rossini,

The American Journal of Cardiology

2015

295

Early Aggressive Versus Initially Conservative Treatment in Elderly Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

Stefano Savonitto, Claudio Cavallini, Anna Sonia Petronio,

JACC: Cardiovascular Interventions

2012

271

Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization

Stefano Savonitto, Luca Ferri, Luigi Piatti,

Circulation

2018

147

Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry

Pasquale Paolisso, Luca Bergamaschi, Felice Gragnano,

Pharmacological Research

2022

140

Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection

Enrico Ammirati, Cristina Cavalotti, Angela Milazzo,

IJC Heart & Vasculature

2021

86

In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study

Arturo Cesaro, Felice Gragnano, Pasquale Paolisso,

Frontiers in Cardiovascular Medicine

2022

84

Elective versus provisional intraaortic balloon pumping in unprotected left main stenting

Carlo Briguori, Flavio Airoldi, Alaide Chieffo,

American Heart Journal

2006

80

Page 1